机制
锐思力（阿利吉仑）作用机制.swf
1.27MB
基础研究
2020+Chemico-Biological Interactions+E-阿利吉仑的抗氧化作用.pdf
548.57KB
2019+Braz J Med Biol Res+Aliskiren attenuates cardiac dysfunction by modulation of the mTOR and .pdf
1.18MB
2019+E-综述：使用阿利吉仑作为抗纤维化药物.pdf
1.71MB
1  /  4
临床研究
阿利吉仑降压疗效及对血尿酸的影响_何杜娟.pdf
225.12KB
阿利吉仑联合氯沙坦对老年高血压性心肌病患者左心室肥厚指标的影响_姚小利.pdf
144.81KB
阿利吉仑联合血管紧张素Ⅱ受体拮抗剂对老年高血压性心肌病患者血压控制及左心室功能的影响.pdf
1.39MB
1  /  7
主要国内文献
口服肾素抑制剂_阿利吉仑的研究进展_连士杰.pdf
115.81KB
临床试验ALLAY_直接肾素抑制剂减少左室肥厚_余国膺.pdf
49.51KB
WONCA研究论文摘要汇编_阿利吉仑用于2型糖尿病心肾终点试验_周淑新.pdf
116.89KB
1  /  8
主要国外文献
@ Comparative efficacy and safety of aliskiren and irbesartan in patients with hypertension and .pdf
420.82KB
Aliskiren penetrates adipose and skeletal muscle tissue and reduces renin-angiotensin system act.pdf
70.40KB
# Direct Renin Inhibition With Aliskiren in Obese Patients, Jordan J, 2007, Hypertension.（IF：6.8.pdf
747.56KB
1  /  4
综述
循证医学证据—IBM MICROMEDEX 1.pdf
587.34KB
2020+American family physician+Managing Hypertension Using Combination Therapy.pdf
563.08KB
2020+Bioorganic & Medicinal Chemistry+Decades-old renin inhibitors are still struggling to find .pdf
785.39KB
1  /  3
厂家提供
文献Andersen.JHyp.589 2008.pdf
320.97KB
文献Drummond.JCH.742.pdf
339.23KB
文献nejm Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes.pdf
578.52KB
1  /  3
COVID-19相关文献
2020+E-综述：阿利吉仑治疗感染COVID-19的高血压患者.pdf
283.45KB
2020+阿利吉仑治疗COVID-19预试验（刘力生教授）.pdf
943.81KB
2020+E-通过分子模拟筛选潜在SARS-COV-2抑制剂.pdf
883.37KB
1  /  2